Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGOBSERVATIONAL

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Efficacy of Advanced Radiotherapy (ART) in Prostate Cancer Patients With Early Stage, Advanced, Metastatic and Relapsed Disease (PROST-ART)

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This is a retrospective monoinstitutional study which analyses the results of advanced radiotherapy (IGRT, IMRT, SBRT, and PET-guided) performed for radical, adjuvant, or salvage purposes in patients with low, intermediate, high, and very high-risk prostate cancer, or with biochemical, lymph node, or oligometastatic recurrence treated between 2004 and 2024. Approved by Ethics Committee of IRCCS San Raffaele Hospital Approval Number: 187/INT/2021, 03/02/2022 Amendment approved by Ethics Committee 1, Lombardy Region Approval number CET Em. 194-2024, 22/05/2024

Who May Be Eligible (Plain English)

Who May Qualify: - Prostate cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT Who Should NOT Join This Trial: - other tumors - \> 95 years old Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Prostate cancer patients, \> 18 years old, treated with IGRT, IMRT, SBRT Exclusion Criteria: * other tumors * \> 95 years old

Treatments Being Tested

RADIATION

Image Guided Radiotherapy

Patients treated with IGRT for Prostate cancer will be evaluated

RADIATION

Intensity Modulated Radiotherapy

Patients treated with IMRT for Prostate cancer will be evaluated

RADIATION

Stereotactic Body Radiotherapy

Patients treated with SBRT for Prostate cancer will be evaluated

Locations (1)

IRCCS San Raffaele Scientific Institute
Milan, Italy